Emma Truin

Mr. Kandel has extensive experience leading leveraged, special situations and acquisition finance and restructuring matters under English and U.S. law, and is considered one of the leading acquisition finance lawyers in London.Significantly, he brings to bear an unusually broad depth of experience beyond his core focus area, having had experience over the years in high-yield and debt capital markets, mergers and acquisitions, securitization, derivatives, margin loans, fund finance, investment...

Al Gourley is a Partner at the firm’s London office. He is a globally-recognised resource lawyer, having led many UK and Canadian initial public offerings, secondary and alternative finance transactions, as well as mergers and acquisitions, in the resource sector, particularly cross-border transactions involving Europe, Africa, Australia and Canada. Al is also the Chairman of the World Initiative of Mining Lawyers based in Europe. Al is known for his knowledge of “pure” mini...

Elisabeth I. Baltay is a top attorney recognized by Best Lawyers in the practice area(s) of Insolvency and Restructuring Law. Elisabeth I., who practices law in London, United Kingdom, has been recognized since 2025. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Elisabeth I. is held by other top lawyers in the same geographic and legal practice area.

Zaneta Wykowska is a top attorney recognized by Best Lawyers in the practice area(s) of Securitisation Law. Zaneta, who practices law in London, United Kingdom, has been recognized since 2025. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Zaneta is held by other top lawyers in the same geographic and legal practice area.

Neil Robson decodes complex UK and EU regulations to provide practical regulatory and compliance advice to financial services firms. He represents a range of financial market participants — hedge and private equity fund managers, investment advisors, broker-dealers and proprietary traders — that are based or doing business in the UK or the EU. Neil's extensive working knowledge of this complicated sector allows his clients to both meet their business objectives and satisfy regulat...

Clients value the support, guidance, and leadership that Phillip Taylor brings to a situation and his technical and commercial approach to delivering innovative solutions to the most complex issues involving international restructuring, special situations, and insolvency. He represents companies, creditors, and investors in all parts of the capital structure, as well as corporate trustees, agents, directors, and insolvency practitioners. Phillip routinely handles both contentious and non-cont...

Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences grou...

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devi...

When multinational corporations consider major transactions, tax implications often make or break the deal. Charlotte Sallabank advises on those implications, advising clients on the direct and indirect tax consequences of their largest business decisions. Her creativity, persuasive power and close attention to her clients' business aspirations consistently result in solutions that make them a reality.A complete perspective on tax-planning issuesWith more than 30 years of experience advising ...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...